Accès gratuit
Med Sci (Paris)
Volume 26, Numéro 8-9, Août-Septembre 2010
Page(s) 719 - 723
Section M/S revues
Publié en ligne 15 août 2010
  1. Johansson S, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the romenclature review committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113 : 832-6.
  2. Moneret-Vautrin DA, Morisset M, Flabbee J, et al. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005; 60 : 443-51.
  3. Gupta R, Sheikh A, Strachan D, Anderson HR. Time trends in allergic disorders in the UK. Thorax 2006; 62 : 91-6.
  4. Poulos LM, Waters AM, Corell P, et al. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. J Allergy Clin Immunol 2007; 120 : 878-84.
  5. Kanny G, Moneret-Vautrin DA, Flabbee J, et al. Population study of food allergy in France. J Allergy Clin Immunol 2001; 108 : 133-40.
  6. Simon MR, Mulla ZD. A population-based epidemiologic analysis of deaths from anaphylaxis in Florida. Allergy 2008; 63 : 1077-83.
  7. Pumphrey R. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30 : 1144-50.
  8. Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 2007; 98 : 252-7.
  9. Brokow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008; 63 : 226-32.
  10. Mueller UR. Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin Immunol 2007; 7 : 337-41.
  11. Liew WK, Williamson E, Tang ML. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol 2009; 123 : 434-42.
  12. Burks AW. Factoring PAF in anaphylaxis. N Engl J Med 2008; 358 : 79-81.
  13. Cowburn AS, Sladek K, Soja J, et al. Overexpression of leukotriene c4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998; 10 : 834-46.
  14. Drouet C, Desormeaux A, Robillard J, et al. Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P. J Allergy Clin Immunol 2007; 121 : 429-3.
  15. Vadas P, Gold M, Perelman B, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 2008; 3 : 28-35.
  16. Dzau VJ. Vascular renin-angiotensin system and vascular protection. J Cardiovasc Pharmacol 1993; 22 : S1-9.
  17. Toogood JH. Risk of anaphylaxis in patients receiving beta-blocker drugs. J Allergy Clin Immunol 1988; 81 : 1-5.
  18. Laxenaire MC, Torrens J, Moneret-Vautrin DA. Fatal anaphylactic shock in a patient treated with beta-blockers. Ann Fr Anesth Reanim 1984; 3 : 453-5.
  19. Moneret-Vautrin DA, Kanny G, Faller J, et al. Severe anaphylactic shock with heart arrest caused by coffee and gum arabic, potentiated by beta-blocking eyedrops. Rev Med Interne 1993; 14 : 107-11.
  20. Dohi M, Suko M, Sjiyama H, et al. Three cases of food-dependent exercise-induced anaphylaxis in which aspirin intake exacerbated anaphylactic symptoms. Aerugi 1990; 39 : 1598-604.
  21. Harada S, Horikawa T, Ashida M, et al. Aspirin enhances the induction of type i allergic symptoms when combined with food and exercise in patients with food-dependent exercise-induced anaphylaxis. Br J Dermatol 2001; 145 : 336-9.
  22. Moneret-Vautrin DA, Latarche C. Médicaments facteurs de risque de sévérité de l’anaphylaxie alimentaire de l’adulte. Étude cas-contrôle. Bull Acad Natl Med 2009; 193 : 51-63.
  23. Inagaki N, Miura T, Nagai H, Koda A. Antiallergic mechanisms of beta-adrenergic stimulants in rats. Life Sci 1992; 51 : 201-5.
  24. Baudin B. L’enzyme de conversion de l’angiotensine 1 (ECA) dans le diagnostic de la sarcoïdose. Pathol Biol 2005; 53 : 183-8.
  25. Adam A, Desormeaux A, Moreau ME. Physiopathology of the acute adverse effects of angiotensin- converting-enzyme inhibitors. Bull Acad Natl Med 2007; 191 : 1433-44.
  26. Gabb GM, Ryan P, Wing LM, Hutchinson KA. Epidemiological study of angioedema and ACE inhibitors. Aust NZ J Med 1996; 26 : 777-82.
  27. Summers CW, Pumphrey RS, Woods CN, et al. Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center. J Allergy Clin Immunol 2008; 121 : 632-8.
  28. Moneret-Vautrin DA, Bilain H, Kanny G, Bloch Y. Anaphylaxis to walnuts and pine nuts induced by ACE. Allergy 1998; 53 : 1233-4.
  29. Hermann K, Von Tschirschnitz M, Ebner von Eschenbach C, Ring J. Histamine, tryptase, norepinephrine, angiotensinogen, angiotensin-converting enzyme, angiotensin i and ii in plasma of patients with hymenoptera venom anaphylaxis. Int Arch Allergy Immunol 1994; 104 : 379-84.
  30. Hermann K, Ring J. The renin-angiotensin system in patients with repeated anaphylactic reactions during hymenoptera venom hyposensitization and sting challenge. Int Arch Allergy Immunol 1997; 112 : 251-6.
  31. Fujii H, Kambe N, Fujisawa A, et al. Food-dependent exercise-induced anaphylaxis induced by low dose aspirin therapy. Allergol Int 2008; 57 : 97-8.
  32. Rabassa AA, Goodgame R, Sutton FM, et al. Effects of aspirin and helicobacter pylori on the gastroduodenal mucosal permeability to sucrose. Gut 1996; 39 : 159-63.
  33. Matsuo H, Morimoto K, Akaki T, et al. Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis. Clin Exp Allergy 2005; 35 : 461-6.
  34. Smecuol E, Bai JC, Sugai E, et al. Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs. Gut 2001; 4 : 650-5.
  35. Aihara M, Miyazawa M, Osuna H, et al. Food-dependent exercise-induced anaphylaxis: influence of concurrent aspirin administration on skin testing and provocation. Br J Dermatol 2002; 146 : 466-72.
  36. Yano H, Kato Y, Matsuo T. Acute exercise induces gastrointestinal leakage of allergen in lysozyme-sensitized mice. Eur J Appl Physiol 2002; 87 : 358-64.
  37. Sudheer PS, Hall JE, Donev R, et al. Nicotinic acetylcholine receptors on basophils and mast cells. Anaesthesia 2006; 61 : 1170-4.
  38. Scholl I, Untersmayr E, Bakos N, et al. Antiulcer drugs promote oral sensitization and hypersensitivity to hazelnut allergens in balb/c mice and humans. Am J Clin Nutr 2005; 81 : 154-60.
  39. Sattler J, Hesterberg R, Lorentz W, et al. Inhibition of human and canine diamine oxidase by drugs used in an intensive care unit: relevance for clinical side effects? Agents Actions 1985; 16 : 91-4.
  40. Korhonen H, Fisslthaler B, Moers A, et al. Anaphylactic shock depends on endothelial gq/g11. J Exp Med 2009; 206 : 411-20.
  41. Rueff F, Przybilla B, Bilo MB, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology interest group on insect venom hypersensitivity. J Allergy Clin Immunol 2009; 124 : 1047-54.
  42. Javeed N, Javeed H, Javeed S, et al. Refractory anaphylactoid shock potentiated by beta-blockers. Cathet Cardiovasc Diagn 1996; 3 : 383-4.
  43. Tenbrook JA, Wolf MP, Hoffman SN, et al. Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis. J Allergy Clin Immunol 2004; 113 : 977-82.
  44. Moneret-Vautrin DA. Le risque allergique et le rôle du Réseau d’allergovigilance Bull Acad Natl Med 2007; 191 : 807-14.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.